Stephanie Sullivan, MD
Gynecologic Oncology · Nashville, TNNPI 1902197288
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,268 of the $4,881 with a category attached, or 87.4%. It is spread thinly across 23 manufacturers, the largest accounting for just 16.0% — the pattern of someone who eats at a lot of different presentations.
Across 160 payments — averaging $30.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$781
- Reflexion Medical, Inc.$600
- GSK$550
- Eisai Inc.$503
- AbbVie$485
- Intuitive Surgical$374
- plus $2K from 17 others
What the payments were for
- Speaking & faculty fees$60012%
- Food & beverage$4,26887%
- Education$130%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 30 | $781 |
| Reflexion Medical, Inc. | 1 | $600 |
| GSK | 26 | $550 |
| Eisai Inc. | 18 | $503 |
| AbbVie | 18 | $485 |
| Intuitive Surgical | 8 | $374 |
| Myriad Genetic Laboratories, Inc. | 10 | $339 |
| AstraZeneca | 16 | $299 |
| Immunogen, Inc. | 5 | $141 |
| Baxter Healthcare | 4 | $129 |
| Tempus AI, Inc | 6 | $128 |
| Novo Nordisk | 1 | $101 |
| Caris MPI, Inc. | 3 | $78 |
| Pfizer | 3 | $68 |
| Daiichi Sankyo Inc. | 2 | $56 |
| Hologic Inc | 1 | $51 |
| Astellas Pharma US Inc | 2 | $46 |
| Verastem, Inc. | 1 | $33 |
| Smith+Nephew | 1 | $32 |
| Stryker | 1 | $25 |
| Seagen Inc. | 1 | $24 |
| Medtronic | 1 | $21 |
| Hologic Sales And Service, LLC | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,881 in reported general payments places this provider in the 60th percentile of 40 gynecologic oncology providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 50 | $2,370 |
| Estradiol | 19 | $1,654 |
| Estradiol (Twice Weekly)Estradiol | 11 | $437 |
| Medroxyprogesterone Acetate | 14 | $366 |
| Fluconazole | 11 | $76 |
Paid to pharmacies, not to this prescriber.
Other gynecologic oncology in Nashville
- Ronald AlvarezNashville$33K
- Michael StanyNashville$13K
- Thomas NumnumNashville$8K
- Lauren PrescottNashville$7K
- Aaron NizamNashville$5K
- Marta CrispensNashville$4K
- Courtney PennNashville$3K
- Laura WilliamsNashville$3K
- Mali SchneiterNashville$3K
- Kirsten JorgensenNashville$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.